Free Trial

OPKO Health (OPK) Competitors

OPKO Health logo
$1.58 +0.03 (+1.60%)
As of 03:23 PM Eastern
This is a fair market value price provided by Massive. Learn more.

OPK vs. LFST, CRVL, OPCH, AVAH, and WGS

Should you buy OPKO Health stock or one of its competitors? OPKO Health's main competitors and comparable companies include LifeStance Health Group (LFST), CorVel (CRVL), Option Care Health (OPCH), Aveanna Healthcare (AVAH), and GeneDx (WGS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does OPKO Health compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and OPKO Health (NASDAQ:OPK) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

LifeStance Health Group has higher revenue and earnings than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B3.17$9.66M$0.1391.00
OPKO Health$606.90M1.92-$225.68M-$0.09N/A

LifeStance Health Group has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market. Comparatively, OPKO Health has a beta of 1.51, indicating that its share price is 51% more volatile than the broader market.

LifeStance Health Group presently has a consensus price target of $12.88, suggesting a potential upside of 8.83%. OPKO Health has a consensus price target of $1.55, suggesting a potential downside of 0.64%. Given LifeStance Health Group's stronger consensus rating and higher possible upside, analysts plainly believe LifeStance Health Group is more favorable than OPKO Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73
OPKO Health
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.33

LifeStance Health Group has a net margin of 3.19% compared to OPKO Health's net margin of -12.40%. LifeStance Health Group's return on equity of 3.39% beat OPKO Health's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group3.19% 3.39% 2.33%
OPKO Health -12.40%-5.88%-3.83%

85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 64.6% of OPKO Health shares are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by company insiders. Comparatively, 44.7% of OPKO Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, OPKO Health had 5 more articles in the media than LifeStance Health Group. MarketBeat recorded 7 mentions for OPKO Health and 2 mentions for LifeStance Health Group. OPKO Health's average media sentiment score of 0.70 beat LifeStance Health Group's score of 0.00 indicating that OPKO Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
OPKO Health
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

LifeStance Health Group beats OPKO Health on 12 of the 16 factors compared between the two stocks.

How does OPKO Health compare to CorVel?

OPKO Health (NASDAQ:OPK) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

OPKO Health has a beta of 1.51, meaning that its stock price is 51% more volatile than the broader market. Comparatively, CorVel has a beta of 1.05, meaning that its stock price is 5% more volatile than the broader market.

OPKO Health currently has a consensus target price of $1.55, suggesting a potential downside of 0.64%. Given OPKO Health's stronger consensus rating and higher probable upside, analysts plainly believe OPKO Health is more favorable than CorVel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OPKO Health
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.33
CorVel
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

64.6% of OPKO Health shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 44.7% of OPKO Health shares are held by company insiders. Comparatively, 39.7% of CorVel shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

CorVel has a net margin of 11.72% compared to OPKO Health's net margin of -12.40%. CorVel's return on equity of 29.92% beat OPKO Health's return on equity.

Company Net Margins Return on Equity Return on Assets
OPKO Health-12.40% -5.88% -3.83%
CorVel 11.72%29.92%17.82%

In the previous week, OPKO Health had 4 more articles in the media than CorVel. MarketBeat recorded 7 mentions for OPKO Health and 3 mentions for CorVel. OPKO Health's average media sentiment score of 0.70 beat CorVel's score of 0.54 indicating that OPKO Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OPKO Health
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CorVel
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

CorVel has higher revenue and earnings than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OPKO Health$606.90M1.92-$225.68M-$0.09N/A
CorVel$958.53M4.02$110.34M$2.2533.54

Summary

OPKO Health beats CorVel on 9 of the 17 factors compared between the two stocks.

How does OPKO Health compare to Option Care Health?

OPKO Health (NASDAQ:OPK) and Option Care Health (NASDAQ:OPCH) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

In the previous week, OPKO Health had 5 more articles in the media than Option Care Health. MarketBeat recorded 7 mentions for OPKO Health and 2 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.24 beat OPKO Health's score of 0.70 indicating that Option Care Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OPKO Health
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Option Care Health
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

OPKO Health presently has a consensus price target of $1.55, suggesting a potential downside of 0.64%. Option Care Health has a consensus price target of $29.92, suggesting a potential upside of 32.17%. Given Option Care Health's stronger consensus rating and higher possible upside, analysts clearly believe Option Care Health is more favorable than OPKO Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OPKO Health
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.33
Option Care Health
0 Sell rating(s)
7 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.50

Option Care Health has a net margin of 3.68% compared to OPKO Health's net margin of -12.40%. Option Care Health's return on equity of 18.74% beat OPKO Health's return on equity.

Company Net Margins Return on Equity Return on Assets
OPKO Health-12.40% -5.88% -3.83%
Option Care Health 3.68%18.74%7.25%

OPKO Health has a beta of 1.51, indicating that its share price is 51% more volatile than the broader market. Comparatively, Option Care Health has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

Option Care Health has higher revenue and earnings than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OPKO Health$606.90M1.92-$225.68M-$0.09N/A
Option Care Health$5.65B0.60$207.59M$1.3317.02

64.6% of OPKO Health shares are owned by institutional investors. Comparatively, 98.1% of Option Care Health shares are owned by institutional investors. 44.7% of OPKO Health shares are owned by insiders. Comparatively, 1.7% of Option Care Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Option Care Health beats OPKO Health on 12 of the 17 factors compared between the two stocks.

How does OPKO Health compare to Aveanna Healthcare?

Aveanna Healthcare (NASDAQ:AVAH) and OPKO Health (NASDAQ:OPK) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.

In the previous week, OPKO Health had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 7 mentions for OPKO Health and 5 mentions for Aveanna Healthcare. OPKO Health's average media sentiment score of 0.70 beat Aveanna Healthcare's score of 0.47 indicating that OPKO Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aveanna Healthcare
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
OPKO Health
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Aveanna Healthcare has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market. Comparatively, OPKO Health has a beta of 1.51, indicating that its stock price is 51% more volatile than the broader market.

88.0% of Aveanna Healthcare shares are owned by institutional investors. Comparatively, 64.6% of OPKO Health shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by company insiders. Comparatively, 44.7% of OPKO Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Aveanna Healthcare has a net margin of 10.56% compared to OPKO Health's net margin of -12.40%. Aveanna Healthcare's return on equity of 80.70% beat OPKO Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Aveanna Healthcare10.56% 80.70% 7.42%
OPKO Health -12.40%-5.88%-3.83%

Aveanna Healthcare has higher revenue and earnings than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aveanna Healthcare$2.43B1.13$225.03M$1.2310.24
OPKO Health$606.90M1.92-$225.68M-$0.09N/A

Aveanna Healthcare presently has a consensus price target of $14.06, indicating a potential upside of 11.64%. OPKO Health has a consensus price target of $1.55, indicating a potential downside of 0.64%. Given Aveanna Healthcare's stronger consensus rating and higher probable upside, equities analysts plainly believe Aveanna Healthcare is more favorable than OPKO Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67
OPKO Health
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.33

Summary

Aveanna Healthcare beats OPKO Health on 12 of the 16 factors compared between the two stocks.

How does OPKO Health compare to GeneDx?

GeneDx (NASDAQ:WGS) and OPKO Health (NASDAQ:OPK) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

GeneDx has a beta of 1.95, meaning that its stock price is 95% more volatile than the broader market. Comparatively, OPKO Health has a beta of 1.51, meaning that its stock price is 51% more volatile than the broader market.

In the previous week, OPKO Health had 2 more articles in the media than GeneDx. MarketBeat recorded 7 mentions for OPKO Health and 5 mentions for GeneDx. GeneDx's average media sentiment score of 0.80 beat OPKO Health's score of 0.70 indicating that GeneDx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GeneDx
1 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
OPKO Health
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

61.7% of GeneDx shares are owned by institutional investors. Comparatively, 64.6% of OPKO Health shares are owned by institutional investors. 25.2% of GeneDx shares are owned by company insiders. Comparatively, 44.7% of OPKO Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

OPKO Health has a net margin of -12.40% compared to GeneDx's net margin of -23.41%. GeneDx's return on equity of 4.12% beat OPKO Health's return on equity.

Company Net Margins Return on Equity Return on Assets
GeneDx-23.41% 4.12% 2.26%
OPKO Health -12.40%-5.88%-3.83%

GeneDx presently has a consensus price target of $90.86, indicating a potential upside of 24.31%. OPKO Health has a consensus price target of $1.55, indicating a potential downside of 0.64%. Given GeneDx's stronger consensus rating and higher probable upside, research analysts clearly believe GeneDx is more favorable than OPKO Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GeneDx
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.89
OPKO Health
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.33

GeneDx has higher earnings, but lower revenue than OPKO Health. GeneDx is trading at a lower price-to-earnings ratio than OPKO Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GeneDx$427.54M5.10-$21.02M-$3.64N/A
OPKO Health$606.90M1.92-$225.68M-$0.09N/A

Summary

GeneDx beats OPKO Health on 9 of the 16 factors compared between the two stocks.

Get OPKO Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPK vs. The Competition

MetricOPKO HealthHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.17B$9.78B$7.16B$13.36B
Dividend YieldN/A2.61%2.53%17.32%
P/E Ratio-17.3934.14274.8526.18
Price / Sales1.924.90614.6793.04
Price / CashN/A22.8227.2234.70
Price / Book0.945.1911.256.40
Net Income-$225.68M$315.68M$3.50B$381.35M
7 Day Performance-3.99%-1.57%-1.57%-0.45%
1 Month Performance-4.57%-2.77%-5.91%-4.34%
1 Year Performance0.32%8.30%7.98%1.90%

OPKO Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPK
OPKO Health
1.0527 of 5 stars
$1.59
+1.6%
$1.55
-2.2%
+0.0%$1.18B$606.90MN/A1,373
LFST
LifeStance Health Group
3.7939 of 5 stars
$11.84
flat
$12.88
+8.7%
+114.7%$4.52B$1.42B91.0810,961
CRVL
CorVel
1.3905 of 5 stars
$73.84
-0.7%
N/A+2.2%$3.79B$958.53M32.825,239
OPCH
Option Care Health
4.0672 of 5 stars
$22.90
-0.7%
$29.92
+30.7%
-17.7%$3.46B$5.65B17.228,266
AVAH
Aveanna Healthcare
4.4237 of 5 stars
$12.69
+2.3%
$14.06
+10.8%
+45.9%$2.71B$2.43B10.3235,500

Related Companies and Tools


This page (NASDAQ:OPK) was last updated on 10/5/2026 by MarketBeat.com Staff.
From Our Partners